A Safety and Efficacy Trial of TTHX1114 in People With CED March 27, 2021checkorphan Learn more about: Corneal endothelial dystrophy type 2 Related Clinical Trial Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection A Safety and Efficacy Trial of TTHX1114 in People With CED Evaluating Results of Neusidl Corneal Inserter in Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK) Recruitment InformationAdministrative Informations
